最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/9/29。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 125
- 預計賣出市值
- $1.55 億
- 賣方
- 24
- 公司
- 13
- 依 10b5-1 計畫
- 82
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| VGNTVersigent PLC | 2026/9/818:28 ET | Kevin Clark高階主管 | 22.0 萬 | $1,043 萬 | 2026/9/810b5-1 | Goldman Sachs & Co. LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/9/814:28 ET | Najat Khan高階主管 | 2.24 萬 | $7.88 萬 | 2026/9/810b5-1 | Merrill Lynch | SEC |
| RSIRush Street Interactive, Inc. | 2026/9/311:04 ET | Sauers Kyle高階主管 | 2.30 萬 | $61.1 萬 | 2026/9/310b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/9/116:21 ET | Borgeson Blake董事 | 3.00 萬 | $10.0 萬 | 2026/9/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/2111:27 ET | Gibson Christopher前董事 | 7.73 萬 | $26.2 萬 | 2026/8/21 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/2011:32 ET | Gibson Christopher前董事 | 7.50 萬 | $25.5 萬 | 2026/8/20 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/1911:54 ET | Gibson Christopher前董事 | 10.0 萬 | $32.8 萬 | 2026/8/19 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/1817:14 ET | Gibson Christopher前董事 | 2.68 萬 | $8.04 萬 | 2026/8/18 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/1312:58 ET | Gibson Christopher前董事 | 10.0 萬 | $33.1 萬 | 2026/8/13 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/1211:56 ET | Gibson Christopher前董事 | 5.00 萬 | $16.9 萬 | 2026/8/12 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/1016:59 ET | Gibson Christopher前董事 | 10.0 萬 | $32.7 萬 | 2026/8/10 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/712:42 ET | Gibson Christopher前董事 | 10.0 萬 | $32.5 萬 | 2026/8/7 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/413:37 ET | Borgeson Blake董事 | 3.00 萬 | $9.75 萬 | 2026/8/410b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/8/410:35 ET | Gibson Christopher前董事 | 7.50 萬 | $24.5 萬 | 2026/8/4 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | 2026/8/316:29 ET | Lori R Schwartz 2025 Gift Trust U/Adtd 03/28/2025董事 · 高階主管 | 16.7 萬 | $448.5 萬 | 2026/8/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | 2026/8/316:27 ET | Richard T Schwartz Revocable Trust U/A DTD 10/25/2024董事 · 高階主管 | 14.2 萬 | $381.2 萬 | 2026/8/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | 2026/8/316:26 ET | Richard T Schwartz 2024 Gift Trust U/A DTD 10/25/2024董事 · 高階主管 | 16.7 萬 | $448.5 萬 | 2026/8/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | 2026/8/310:27 ET | Sauers Kyle高階主管 | 2.30 萬 | $61.3 萬 | 2026/8/310b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/3016:10 ET | Gibson Christopher前董事 | 7.50 萬 | $22.5 萬 | 2026/7/30 | Fidelity Brokerage Services LLC | SEC |
| GOOGAlphabet Inc. | 2026/7/2916:20 ET | Marsida Saraci高階主管 | 449 | $14.9 萬 | 2026/7/2910b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/2916:09 ET | Gibson Christopher前董事 | 5.00 萬 | $15.1 萬 | 2026/7/29 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/2716:16 ET | Gibson Christopher前董事 | 5.00 萬 | $15.3 萬 | 2026/7/27 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/2116:11 ET | Gibson Christopher前董事 | 10.0 萬 | $30.4 萬 | 2026/7/21 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/2016:11 ET | Gibson Christopher前董事 | 10.0 萬 | $29.0 萬 | 2026/7/20 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/1716:10 ET | Gibson Christopher前董事 | 10.0 萬 | $29.7 萬 | 2026/7/17 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/1616:13 ET | Gibson Christopher前董事 | 10.0 萬 | $31.1 萬 | 2026/7/16 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/1516:12 ET | Gibson Christopher前董事 | 12.3 萬 | $41.0 萬 | 2026/7/15 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/1416:07 ET | Gibson Christopher前董事 | 10.0 萬 | $33.0 萬 | 2026/7/14 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/1316:32 ET | Gibson Christopher前董事 | 10.0 萬 | $34.3 萬 | 2026/7/13 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/1016:09 ET | Gibson Christopher前董事 | 10.0 萬 | $35.4 萬 | 2026/7/10 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/916:26 ET | Gibson Christopher前董事 | 28.6 萬 | $108.6 萬 | 2026/7/9 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/816:26 ET | Gibson Christopher前董事 | 20.0 萬 | $73.8 萬 | 2026/7/8 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/713:39 ET | Gibson Christopher前董事 | 25.0 萬 | $98.8 萬 | 2026/7/7 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/711:36 ET | Borgeson Blake董事 | 4.00 萬 | $15.8 萬 | 2026/7/710b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/615:28 ET | Gibson Christopher前董事 | 10.0 萬 | $37.8 萬 | 2026/7/6 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | 2026/7/610:07 ET | Sauers Kyle高階主管 | 2.30 萬 | $72.5 萬 | 2026/7/610b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/212:54 ET | Gibson Christopher前董事 | 10.0 萬 | $37.5 萬 | 2026/7/2 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/7/117:19 ET | Gibson Christopher前董事 | 10.0 萬 | $36.7 萬 | 2026/7/1 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | 2026/7/116:49 ET | Sona Trust U/A DTD 05/09/2025高階主管 | 6.00 萬 | $178.4 萬 | 2026/7/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Orion Diversified Holding Co., IncCommon | 2026/6/3015:25 ET | Lull Thomas Ryan高階主管 | 11.9 萬 | $4.16 萬 | 2026/6/22 | OCOF Securities Limited | SEC |
| GOOGAlphabet Inc. | 2026/6/2616:31 ET | Marsida Saraci高階主管 | 449 | $15.4 萬 | 2026/6/2610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RSIRush Street Interactive, Inc. | 2026/6/2515:17 ET | Wierbicki Paul高階主管 · 董事 | 1.00 萬 | $30.1 萬 | 2026/6/25 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/6/1816:33 ET | Gibson Christopher董事 | 30.0 萬 | $96.2 萬 | 2026/6/18 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/6/1809:44 ET | Bumpus Namandje董事 | 3,963 | $1.26 萬 | 2026/6/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/6/1809:37 ET | Gibson Christopher董事 | 4.00 萬 | $12.7 萬 | 2026/6/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/6/513:29 ET | Najat Khan高階主管 | 2.36 萬 | $8.45 萬 | 2026/6/510b5-1 | Merrill Lynch | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/6/510:19 ET | Gibson Christopher董事 | 4.00 萬 | $14.5 萬 | 2026/6/510b5-1 | Fidelity Brokerage Services LLC | SEC |
| RSIRush Street Interactive, Inc. | 2026/6/311:20 ET | Sauers Kyle高階主管 | 2.30 萬 | $58.5 萬 | 2026/6/310b5-1 | Fidelity Brokerage Services LLC | SEC |
| RXRXRecursion Pharmaceuticals, Inc. | 2026/6/310:16 ET | Bumpus Namandje董事 | 4,386 | $1.55 萬 | 2026/6/310b5-1 | Fidelity Brokerage Services LLC | SEC |
| LEALear Corp | 2026/6/211:39 ET | Orsini Frank C高階主管 | 5,000 | $74.3 萬 | 2026/6/2 | Fidelity Brokerage Services LLC | SEC |